Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04150497
Title Phase I Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Indications

acute lymphoblastic leukemia

Therapies

UCART22

Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
University of California, Los Angeles (UCLA) - Medical Center Recruiting Los Angeles California 90095 United States Details
University of Chicago Recruiting Chicago Illinois 60647 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center (MSKCC) David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Recruiting New York New York 10021 United States Details
Weill Medical College of Cornell University Withdrawn New York New York 10065 United States Details
Children's Hospital of Philadelphia Recruiting Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Hôpital Robert Debré - Service d'hémato-immunologie Recruiting Paris 75935 France Details
Hôpital Saint Louis, Unité d'Hématologie Adolescents et Jeunes Adultes Département d'Hématologie Recruiting Paris 75935 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field